Glanbia PLC
ISEQ:GL9

Watchlist Manager
Glanbia PLC Logo
Glanbia PLC
ISEQ:GL9
Watchlist
Price: 10.47 EUR 1.65% Market Closed
Market Cap: 2.7B EUR

Glanbia PLC
Investor Relations

Glanbia PLC, with roots firmly embedded in the Emerald Isle, is a testament to the evolution and innovation in the global food industry. Originally emerging from the dairy cooperatives of Ireland, Glanbia has masterfully transformed itself from a local dairy operation into a global nutritional powerhouse. At the heart of its operations is a deep-seated commitment to nutrition – crafting products that cater to the growing global demand for healthier, functional foods. The company's business model is intricately woven around two core divisions: Glanbia Performance Nutrition, which crafts and supplies a diverse portfolio of performance nutrition products, and Glanbia Nutritionals, which delivers bespoke nutritional solutions through its comprehensive dairy and non-dairy ingredients. These synergistic divisions allow Glanbia to tap into and steer multiple nodes of the health and wellness megatrend.

The financial heartbeat of Glanbia comes from its ability to marry science with nutritional innovation. By leveraging advanced research and development capabilities, the company consistently innovates, ensuring its offerings remain at the cutting edge of consumer trends. Glanbia Performance Nutrition's leading brands like Optimum Nutrition and SlimFast cater to fitness enthusiasts and health-conscious consumers, translating into robust sales globally. Meanwhile, Glanbia Nutritionals' sophisticated ingredients and solutions, utilized by leading brands in the food and beverage industry, underpin a reliable revenue stream. This dual-engine strategy ensures Glanbia not only meets current market demands but is also strategically positioned to adapt to the fluid dynamics of the health-focused consumer marketplace. Through this, Glanbia PLC fortifies its standing as not just a company, but a vital participant in the global narrative of nutritional well-being.

Show more
Loading

Earnings Calls

2025 Q4
Mar 5, 2025
Show Transcript
Previous
Next
Strong financial results and growth plans heading into 2025
2025 Q4
Mar 5, 2025

Abercrombie & Fitch reported a successful fourth quarter with a 9% increase in net sales, reaching $1.58 billion. The company achieved a remarkable 16% annual sales growth and a 72% rise in earnings per share to $10.69. Both Hollister and Abercrombie experienced double-digit growth, with net sales increasing by 15% and 16%, respectively. For 2025, the company expects sales growth of 3% to 5% from $4.95 billion, with operating margins projected between 14% and 15%. They plan to repurchase $100 million in shares quarterly while aiming for sustainable growth and customer engagement.

Show Full Analysis

Management

Mr. Mark A. Garvey
CFO & Executive Director
No Bio Available
Mr. Hugh McGuire Dip Finance, M.Sc
CEO & Executive Director
No Bio Available
Mr. Liam Hennigan
Group Secretary & Head of Investor Relations
No Bio Available
Ms. Martha Kavanagh
Head of Corporate Communications
No Bio Available
Mr. Ian Doyle
Chief Corporate Development Officer
No Bio Available
Ms. Sue Sweem
Chief Human Resources Officer
No Bio Available
Mr. Michael Patten
Chief ESG & Corporate Affairs Officer
No Bio Available
Mr. Tom Tench
Chief Operating Officer of Glanbia Nutritionals
No Bio Available
Mr. Brian Phelan B. Comm, FCA
Chief Executive Officer of Glanbia Nutritionals
No Bio Available
Mr. Jim Bergin B. Comm
Chief Executive of Glanbia Ingredients Ireland Limited
No Bio Available

Contacts

Address
KILKENNY
KILKENNY
Glanbia House, Ring Road
Contacts
+353567772200.0
www.glanbia.com